Gly82Ser polymorphism of the receptor of advanced glycation end product gene is not associated with coronary heart disease in Finnish nondiabetic subjects or in patients with type 2 diabetes (letter)

Pulkkinen A; Viitanen L; Kareinen A; Lehto S; Laakso M

首页> 外文期刊>Diabetes care >Gly82Ser polymorphism of the receptor of advanced glycation end product gene is not associated with coronary heart disease in Finnish nondiabetic subjects or in patients with type 2 diabetes (letter)

【24h】

Gly82Ser polymorphism of the receptor of advanced glycation end product gene is not associated with coronary heart disease in Finnish nondiabetic subjects or in patients with type 2 diabetes (letter)

机译：晚期糖基化终产物基因受体的Gly82Ser多态性与芬兰非糖尿病受试者或2型糖尿病患者的冠心病无关（字母）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Diabetes care》 |2000年第6期|共1页
作者
Pulkkinen A; Viitanen L; Kareinen A; Lehto S; Laakso M;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;护理学;
关键词
Coronary Disease; Diabetes Mellitus; Non-Insulin-Dependent; Diabetic Angiopathies; 冠状动脉疾病; 糖尿病; 非胰岛素依赖型; 糖尿病血管病; 受体; 免疫;

机译：Coronary Disease;Diabetes Mellitus;Non-Insulin-Dependent;Diabetic Angiopathies;冠状动脉疾病;糖尿病;非胰岛素依赖型;糖尿病血管病;受体;免疫;

相似文献

外文文献
中文文献
专利

1. Gly82Ser polymorphism of the receptor of advanced glycation end product gene is not associated with coronary heart disease in Finnish nondiabetic subjects or in patients with type 2 diabetes (letter) [J] . Pulkkinen A, Viitanen L, Kareinen A, Diabetes care . 2000,第6期

机译：晚期糖基化终产物基因受体的Gly82Ser多态性与芬兰非糖尿病受试者或2型糖尿病患者的冠心病无关（字母）
2. Total Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products as Predictive Biomarkers of Coronary Heart Disease Risk in Patients With Type 2 Diabetes [J] . Helen M. Colhoun, D. John Betteridge, Paul Durrington, Diabetes . 2011,第9期

机译：糖基化终末产物的总可溶性和内源性分泌受体作为2型糖尿病患者冠心病风险的预测生物标志物
3. LV systolic impairment in patients with asymptomatic coronary heart disease and type 1 diabetes is related to coronary atherosclerosis, glycaemic control and advanced glycation endproducts. [J] . Steine K, Larsen JR, Stugaard M, European journal of heart failure: journal of the Working Group on Heart Failure of the European Society of Cardiology . 2007,第10期

机译：无症状冠心病和1型糖尿病患者的左室收缩功能障碍与冠状动脉粥样硬化，血糖控制和晚期糖基化终产物有关。
4. L162V Polymorphism of Peroxisome Proliferator-Activated Receptor-Alpha Gene and Cardiac Remodeling in Coronary Heart Disease Patients in Russian Population [C] . Sergeeva E.G., Kostareva A.A., Saha S., International Congress on Coronary Artery Disease. . 2013

机译：俄罗斯人口冠心病患者的过氧化物体增殖物激活受体-α基因和心脏重塑的L162V多态性
5. Pomen izbranih genskih polimorfizmov pri nastanku diabeti?ne ledvi?ne bolezni pri bolnikih s sladkorno boleznijo tipa 2 =Role of selected gene polymorphisms in the development of diabetic kidney disease in patients with type 2 diabetes mellitus [D] . Seruga, Maja. 2018

机译：选定的遗传多态性在糖尿病肾脏发生中的意义 - 糖尿病患者患者2 =糖尿病肾脏疾病中选定基因多态性的卷和2型糖尿病患者
6. Total Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products as Predictive Biomarkers of Coronary Heart Disease Risk in Patients With Type 2 Diabetes [O] . Helen M. Colhoun, D. John Betteridge, Paul Durrington, 2011

机译：糖基化终末产物的总可溶性和内源性分泌受体作为2型糖尿病患者冠心病风险的预测生物标志物
7. Gly82Ser polymorphism of the receptor of advanced glycation end product gene is not associated with coronary heart disease in Finnish nondiabetic subjects or in patients with type 2 diabetes [O] . A. Pulkkinen, L. Viitanen, A. Kareinen, 2000

机译：Gly82Ser高级糖化末端产物基因受体的多态性与芬兰非糖尿病受试者或2型糖尿病患者的冠心病无关

Gly82Ser polymorphism of the receptor of advanced glycation end product gene is not associated with coronary heart disease in Finnish nondiabetic subjects or in patients with type 2 diabetes (letter)

著录项

相似文献

相关主题

期刊订阅